Nippon Life Global Investors Americas’s Elanco Animal Health ELAN Stock Holding History

Nippon Life Global Investors Americas’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-88,260	Closed	-$1.73M	–	134
2022 Q2	$1.73M	Sell	88,260 -15,540	-15%	-$368K	0.11%	121
2022 Q1	$2.71M	Buy	103,800 +20,660	+25%	+$550K	0.14%	114
2021 Q4	$2.36M	Hold	83,140	–	–	0.11%	128
2021 Q3	$2.65M	Hold	83,140	–	–	0.14%	122
2021 Q2	$2.88M	Buy	83,140 +10,450	+14%	+$345K	0.14%	120
2021 Q1	$2.14M	Hold	72,690	–	–	0.12%	130
2020 Q4	$2.23M	Buy	+72,690	New	+$2.22M	0.13%	119
2020 Q3	–	Sell	-97,550	Closed	-$2.09M	–	145
2020 Q2	$2.09M	Sell	97,550 -49,490	-34%	-$1.09M	0.15%	114
2020 Q1	$3.29M	Sell	147,040 -233,970	-61%	-$6.41M	0.29%	82
2019 Q4	$11.2M	Buy	381,010 +29,020	+8%	+$789K	0.76%	46
2019 Q3	$9.36M	Sell	351,990 -162,490	-32%	-$4.87M	0.69%	49
2019 Q2	$17.4M	Sell	514,480 -1,620	-0.3%	-$52.6K	1.32%	23
2019 Q1	$16.6M	Buy	516,100 +455,260	+748%	+$14M	1.33%	21
2018 Q4	$1.92M	Buy	+60,840	New	+$1.99M	0.17%	119

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nippon Life Global Investors Americas's ELAN Position: Q3 2022 in Review

Nippon Life Global Investors Americas sold out of Elanco Animal Health (ELAN) in Q3 2022, closing a stake of 88,260 shares — an estimated $1.73M sold.

Nippon Life Global Investors Americas first reported a position in ELAN in Q4 2018 and held it in 14 quarters. The position peaked at $17.4M in Q2 2019. 419 funds tracked by Wall St. Rank hold ELAN as of Q3 2022.

Nippon Life Global Investors Americas reported no remaining Elanco Animal Health position as of Q3 2022 after selling out during the quarter.
Nippon Life Global Investors Americas sold 88,260 Elanco Animal Health shares in Q3 2022, an estimated $1.73M.
Nippon Life Global Investors Americas first reported a position in Elanco Animal Health in Q4 2018 and held it in 14 quarters.
Nippon Life Global Investors Americas's Elanco Animal Health position peaked at $17.4M in Q2 2019.
419 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2022.

Based on Nippon Life Global Investors Americas's 13F filing for Q3 2022, filed 14 Nov 2022.